Filing Details
- Accession Number:
- 0001358403-17-000079
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-26 15:07:07
- Reporting Period:
- 2017-05-25
- Filing Date:
- 2017-05-26
- Accepted Time:
- 2017-05-26 15:07:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1358403 | Bellicum Pharmaceuticals Inc | BLCM | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1295830 | A Alan Musso | C/O Bellicum Pharmaceuticals, Inc. 2130 W. Holcombe Blvd., Ste. 800 Houston TX 77030 | Cfo And Treasurer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-05-25 | 6,311 | $12.24 | 54,908 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents shares sold to satisfy tax liabilities and withholding obligations in connection with vesting of 14,706 shares of common stock from the Restricted Stock Awards granted to the Reporting Person on December 17, 2014.
- Includes 671 shares acquired under the Issuer's Employee Stock Purchase Plan on December 9, 2016.
Billionaire Hedge Funds
